Cefpodoxime proxetil concentrations in head and neck tissues
- PMID: 2013507
- DOI: 10.1007/BF01643757
Cefpodoxime proxetil concentrations in head and neck tissues
Abstract
Three to six hours prior to surgery in the head and neck a single dose of 200 mg cefpodoxime proxetil was administered orally to 30 patients. During surgery serum and tissue samples (concha, mocosa, cartilage, bone, parotis and tonsil) were taken and the concentrations of cefpodoxime were determined by bioassay. The serum concentrations ranged from 0.72 mg/l (determined after 6 h 22 min) to 3.34 mg/l (3 h 15 min). The tissue concentrations were between 0.15 mg/l (determined in bone after 5 h 18 min) and 1.94 mg/l (concha 4 h 13 min). Analogously to recent in vitro data the concentrations reached in head and neck tissue were higher than the MIC90 values for most pathogens of upper respiratory tract infections.
Similar articles
-
Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.Drugs. 1992 Nov;44(5):889-917. doi: 10.2165/00003495-199244050-00011. Drugs. 1992. PMID: 1280571 Review.
-
Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.J Antimicrob Chemother. 1990 Dec;26 Suppl E:47-51. doi: 10.1093/jac/26.suppl_e.47. J Antimicrob Chemother. 1990. PMID: 2292530
-
Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.J Antimicrob Chemother. 1992 Jul;30(1):67-71. doi: 10.1093/jac/30.1.67. J Antimicrob Chemother. 1992. PMID: 1429338
-
Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.J Antimicrob Chemother. 1990 Dec;26 Suppl E:41-6. doi: 10.1093/jac/26.suppl_e.41. J Antimicrob Chemother. 1990. PMID: 2292529
-
A review of the pharmacokinetics of cefpodoxime proxetil.Drugs. 1991;42 Suppl 3:13-21. doi: 10.2165/00003495-199100423-00005. Drugs. 1991. PMID: 1726203 Review.
Cited by
-
Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.Drugs. 1992 Nov;44(5):889-917. doi: 10.2165/00003495-199244050-00011. Drugs. 1992. PMID: 1280571 Review.
-
Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.Paediatr Drugs. 2001;3(2):137-58. doi: 10.2165/00128072-200103020-00006. Paediatr Drugs. 2001. PMID: 11269640 Review.